Navigation Links
ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Date:3/18/2011

/p>

The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials.

Cinryze is for intravenous use only. Per the U.S. label, a dose of 1000 Units of Cinryze can be administered every 3 or 4 days for routine prophylaxis against angioedema attacks in HAE patients. Cinryze is administered at an injection rate of 1 mL per minute.

About Hereditary Angioedema (HAE)

HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States and approximately similar demographics in the European Union.

For more information on HAE, visit the U.S. HAE Association's website at: www.haea.org or the HAEi (International Patient Organization for C1 Inhibitor Deficiencies) at www.haei.org.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 A team of ... structure of a cell-surface receptor that plays a critical ... unexpectedly discloses many new structural features, which challenge the ... (GPCRs) and open a new door for future drug ... Nature on March 30, the researchers at Shanghai ...
(Date:3/30/2015)... March 30, 2015  MedAptus® today announced the ... to simplify pre-care needs for busy inpatient provider ... automatically assign patients to hospitalists or other rounding ... and other requirements such as ensuring patient safety, ... In an ...
(Date:3/30/2015)... 30, 2015 NiQ Health, ... announced the high level interface capabilities of their ... systems. The partnership between CarePlus™ and ... this allows patients to choose the most appropriate ... acuity. The advanced functionality of CarePlus™ allows patient ...
Breaking Medicine Technology:New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 3New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 4New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 5New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 6MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2
... BEVERLY, Mass., Sept. 27, 2011 Sensitech Inc., ... the TempTale ® 4 Intrinsically Safe monitor, its ... safely and accurately monitor the environmental conditions of ... explosive and flammable elements.  The introduction of the ...
... Biodel Inc. (Nasdaq: BIOD ) today ... of BIOD-105 and BIOD-107 at Oregon Health and Sciences ... tolerability profiles of these ultra-rapid-acting formulations of recombinant human ... insulin pumps.     The trial was ...
Cached Medicine Technology:Sensitech Inc. Introduces Temperature and Humidity Monitor for Flammable and Hazardous Environments 2Biodel Reports Top-Line Results From Pump Study of Experimental Insulins 2
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 Foundations ... proud to announce the start of its 41st national ... author Jane McGonigal, and former Congressman Patrick J. Kennedy ... Conference being held in San Diego, CA, March ... Coronado. The national conference brings together leading experts specializing ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 The Consumer Attorneys ... Skills for the New Attorney” seminar for attorneys who passed ... brings top trial attorneys in the Southern California area to ... Doctors on Liens was on hand, not ... to the doctors their clients will need to help in ...
(Date:3/30/2015)... March 30, 2015 KIND LED’s suite of ... light products in 2015. The excellent value and product features ... take the pole position in the race for the best ... the KIND LED suite of grow lights is the ... Photosynthetic Active Radiation (PAR) wavelengths that plants are most likely ...
(Date:3/30/2015)... Healtheminds, a start-up focusing on providing high ... easy to use and engaging online platform, is launching ... health related issues. The first in the series is ... other drugs. , Consumption and use of alcohol ... the toxic effects of excessive intake or drug overdoses, ...
(Date:3/30/2015)... 2015 Dr. Jeffrey Allred DDS, with his ... minute second opinion consultations for patients who need ... on dental second opinions show how small percentage of dentistry ... works. Only 6%” – says Dr. Allred. , “People ... fully trusting the dental care provider, for the simple fact ...
Breaking Medicine News(10 mins):Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:Doctors on Liens Sponsors New Personal Injury Attorneys in Los Angeles 2Health News:Doctors on Liens Sponsors New Personal Injury Attorneys in Los Angeles 3Health News:Best LED Grow Lights of 2015 Are Being Led By KIND LED 2Health News:HealthEminds Launching Webinar on Drug Dependence 2Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2
... Cancer Center researchers have identified a new population of intestinal ... colorectal cancer. , This new stem cell population, reported March ... relatively quiescent (inactive) in contrast to the recent discovery ... marked by a protein, Lrig1, that may act as a ...
... Ill. -- The American Society for Gastrointestinal Endoscopy (ASGE) ... program specifically dedicated to promoting quality in endoscopy, in ... States. The ASGE Endoscopy Unit Recognition Program honors endoscopy ... assurance, endoscope reprocessing and CDC infection control guidelines. To ...
... News) -- Tourists over age 65 who visit malaria-infested regions are ... those ages 18 to 35, a new study says. The ... patients also found that the malaria death rate is particularly high ... of dying from malaria, an infection carried by mosquitoes, increased with ...
... with intensity modulated radiation therapy (IMRT) instead of standard ... acute or chronic toxicities, according to a study in ... official clinical practice journal of the American Society for ... determine the most effective breast cancer treatment that also ...
... 27 (HealthDay News) -- Women with ovarian cancer who ... have annual incomes of less than $35,000 are more ... Researchers found these racial and socioeconomic disparities in ... of surviving for five years after their cancer diagnosis. ...
... have identified genetic causes in nearly 1 in 5 patients ... Carolyn Jones, MD, PhD, of Loyola University Medical Center, ... of Cardiac Failure . First author is Neal Lakdawala, MD, ... on 264 patients with dilated cardiomyopathy and found that 17.4 ...
Cached Medicine News:Health News:Newly identified stem cells may hold clues to colon cancer 2Health News:ASGE recognizes 18 endoscopy units for quality 2Health News:Older Travelers at Much Higher Risk of Dying From Malaria 2Health News:IMRT reduces risk of side effects in breast cancer patients 2Health News:Black Women, Uninsured Get Worse Ovarian Cancer Care: Study 2Health News:Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure 2
...
... Blitz Suture Retriever is for arthroscopic and open ... design eliminates complicated procedural steps. It may ... suture material and in conjunction with,anchors or screws ... small, curved needle tip permits the placement of ...
The Nordt Knot Tightener allows both pushing and spreading of knots, reproducing identical techniques,used when tying traditional open knots. The Nordt Knot Tightener allows tying of any type of s...
Single step suture passage is made simple with Arthro-Pierce instruments. The low profile, highly sharpened tip allows easy passage through tissue in order to retrieve or apply suture....
Medicine Products: